Artelon Secures Funding to Advance Treatment of Joint Instability

Artelon Flexband SOLO

Artelon closed approximately $20 million in Series B funding. The financing will support commercial growth, clinical research and expansion of Artelon’s product line for the surgical treatment of ankles and other joints.

Artelon’s Dynamic Matrix technology is a proprietary polymeric bio-textile for musculoskeletal soft tissue reconstruction....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us